Dana Constantinescu – General Manager, GSK Romania
Dana Constantinescu of GSK Romania reveals the importance of the affiliate to the regional group and how vaccines and HIV are driving its growth. She outlines how the affiliate’s portfolio…
Address: Opera Center 1, Str. Costache Negri nr. 1-5, Sector 5, Cod 050552, Bucuresti, Romania
Tel: +40 21 302 8 208
By everything we do in Romania, we want to improve the quality of life. We are in Romania for over 20 years and we have got strong roots here: we have production of medicines GMP standards (Good Manufacturing Practice) in the heart of the country in Brasov and one of the most important local distribution companies pharmaceutical Europharm Distribution, with a portfolio of over 3,400 products. GSK Consumer Healthcare markets such well known brands Coldrex, Parasinus, Panadol, Vitamax, Eurovita, Sensodyne, Cetebe , alli, Corega . We also have a strong and motivated team. With over 1,000 people involved in these activities, production, distribution and sale of our products, GSK is now one of the leading local employers in the pharmaceutical industry. And people’s involvement and dedication of our team have made GSK to be appointed, in 2010, ‘Best employer in Romania’, in a study conducted by consulting company Hewitt Associates.
For professionals and patients in Romania to have access to innovative treatments, we have a vast portfolio of over 84 products. They cover major therapeutic areas – respiratory, urology, HIV, hematology, oncology, dermatology, neurology, antibiotics and metabolic. In addition, we have a comprehensive portfolio of pediatric vaccines, with over 10 vaccines to prevent serious diseases that can have dramatic consequences on the health of people, such as polio, hepatitis, pneumonia, meningitis and cervical cancer.
Dana Constantinescu of GSK Romania reveals the importance of the affiliate to the regional group and how vaccines and HIV are driving its growth. She outlines how the affiliate’s portfolio…
The general manager of a British pharma giant with over 25 years of presence in Romania discusses how vaccination programs can play a significant role in increasing the cost-effectiveness of the…
After an international career of 15 years with Eli Lilly, you are quite new to both the country as well as the company. Looking back at these first 7 months,…
The country manager of a leading specialty care bio-business reveals how the economic and geo-social fundamentals in Romania are highly attractive from an innovative pharmaceutical producer standpoint. He speaks about…
The longstanding GM of one of the foremost data management services companies for Romanian healthcare analyses some of the key trends sweeping the industry while at he same time outlining…
The founder of the group explains how the pharmacy chain has become a regional trailblazer by redefining the concept of ‘neighborhood pharmacy’ along the principles of being cheap, near and…
The association’s longtime executive director outlines the opportunities and challenges for generics companies in the Romanian market. Analyzing in depth the local market regulatory landscape, he proposes modifications to the…
One of the new generation of pharmaceutical general managers in Romania discusses the complexities of introducing innovative therapies on the market and explains how the country has become the ‘to-go-to’…
One of the so-called ‘new generation’ of pharmaceutical GMs in Romania outlines his first impressions of the local market and details how MSD has managed to shape in-county developments in…
The GM of one of the leading generics companies on the Romanian market shares insights into why generics penetration remains underdeveloped and the importance of having an export strategy and…
The president of the association representing clinical research organisations speaks out about Romania’s attractiveness as a destination country in an era of clinical research globalisation. He further sheds ideas on…
Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s pharmaceutical market. Over these five decades, thorough…
To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have been your main milestones…
Within a broad assessment of Romania’s investment climate, there is no doubt that every country has some key factors upon which can be capitalized to attract foreign investors. In sum,…
You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our readers an idea on how the market environment was at that…
See our Cookie Privacy Policy Here